Abstract
Real-World Effectiveness of Ubrogepant for the Acute Treatment of Migraine When Used in Combination With an Anti-Calcitonin Gene–Related Peptide Monoclonal Antibody Preventive: Results From the COURAGE Study (P10-2.003)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have